超声检测对乳腺癌新辅助化疗患者术后病理缓解程度及预后的预测价值
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

国家自然科学基金青年项目基金(81501567)


Prognostic value of ultrasound diagnosis in predicting the degree of postoperative pathological remission and prognosis of breast cancer patients undergoing neoadjuvant chemotherapy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】 目的 探讨超声诊断对乳腺癌新辅助化疗(NAC)患者术后病理缓解程度及预后的预测价值。 方法 选取2016年3月~2018年10月在西安医学院第一附属医院实施乳腺癌NAC并择期手术治疗的患者82例,患者均在化疗结束后、手术前进行超声检查,根据Mliier&Payne分级将术后病理缓解程度分为组织学非显著反应组(NMHR组)与组织学显著反应组(MHR组)。术后患者均随访1年,根据患者生存情况分为生存组与死亡组。比较NMHR组与MHR组、生存组与死亡组的超声诊断参数差异。以受试者工作特征曲线(ROC)评价化疗前超声诊断参数对术后病理缓解程度的预测价值,Logistic回归分析及ROC分析化疗前超声参数对死亡的预测价值。 结果 NMHR组的病灶直径、血流分级大于MHR组,搏动指数(PI)、阻力指数(RI)小于MHR组,差异均有统计学意义(P<0.001)。死亡组的病灶直径、血流分级大于生存组,NMHR组PI、RI均小于MHR组,差异均有统计学意义(P<0.001)。病灶直径预测术后NMHR的最佳截断点、灵敏度、特异度、AUC分别为6.45 cm、80.49%、70.73%、0.84;PI分别为0.58、85.37%、78.05%、0.90;RI分别为0.47、89.02%、86.59%、0.93;血流分级分别为1.88,80.49%、68.29%、0.78。Logistic回归分析显示病灶直径、PI、RI、血流分级是影响患者死亡的危险因素。病灶直径预测术后死亡的最佳截断点、灵敏度、特异度、AUC分别为8.01cm、80.00%、76.25%、0.81;PI分别为0.38、82.50%、77.50%、0.88;RI分别为0.25、92.50%、82.50%、0.95;血流分级分别为2.01、73.75%、70.00%、0.75。 结论 超声检测参数可准确反应乳腺癌NAC后的组织学病理状态,病灶直径、PI、RI、血流分级是影响术后死亡的危险因素,对预测NAC术后病理缓解程度及预后有较高的临床价值。

    Abstract:

    【Abstract】 Objective To analyze the predictive value of ultrasound diagnosis for pathological remission and prognosis of breast cancer patients after neoadjuvant chemotherapy (NAC). Methods 82 patients with breast cancer underwent NAC and selective surgery in the hospital from March 2016 to October 2018 were selected. After chemotherapy and before operation, all patients were examined by ultrasonography. According to Mliier & Payne classification, the degree of postoperative pathological remission was divided into histological nonmajor histological response group (NMHR group) and major histological response group (MHR group). The patients were followed up for 1 year after operation, and were divided into survival group and death group according to the survival status of the patients. The differences of ultrasonic diagnostic parameters between NMHR group and MHR group, survival group and death group were compared. The receiver operating characteristic curve (ROC) was used to evaluate the predictive value of ultrasound diagnostic parameters before chemotherapy on postoperative NMHR. Logistic regression analysis and ROC analysis were used to predict the predictive value of ultrasound parameters before chemotherapy. Results The diameter of lesions and blood flow grades in the NMHR group were larger than those in the MHR group, and the pulsatility index (PI) and resistanceindex (RI) were smaller than those in the MHR group (P<0.001). The diameter of lesions and blood flow grades in death group were larger than those in survival group, PI and RI were smaller than those in MHR group (P<0.001). Lesiondiameter predicted the best truncation point, sensitivity, specificity, and AUC of NMHR after surgery were 6.45cm, 80.49%, 70.73%, and 0.84, respectively. The PI were 0.58, 85.37%, 78.05%, and 0.90, respectively. The RI were 0.47, 89.02%, 86.59%, and 0.93, respectively. The blood flow grades were 1.88, 80.49%, 68.29%, and 0.78, respectively. Logistic regression analysis showed that lesion diameter, PI, RI, and blood flow grades were risk factors that affected patients' death. The optimal truncation point, sensitivity, specificity, and AUC for predicting postoperative death by lesion diameter were 8.01cm, 80.00%, 76.25%, and 0.81, respectively. The PI is 0.38, 82.50%, 77.50%, 0.88, respectively. The RI is 0.25, 92.50%, 82.50%, 0.95, respectively. The blood flow grades were 2.01, 73.75%, 70.00%, and 0.75%, respectively. Conclusion Ultrasound diagnostic parameters can accurately reflect the histopathological status of breast cancer patients after NAC, Lesion diameter, PI, RI, and blood flow grading are risk factors that affect postoperative death, and have high clinical value for predicting the degree of pathological remission and prognosis after NAC.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2020-09-22
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司